Bright Biologics LLC
Bright Biologics LLC, located in Sunnyvale, CA, is dedicated to developing next-generation bispecific and multispecific antibody drugs aimed at enhancing cancer treatment outcomes. By utilizing VHH antibodies as building blocks, the company is focused on addressing the challenges posed by solid tumors, particularly those associated with treatment resistance and unmet medical needs.
With an emphasis on creating innovative bispecific antibody-drug conjugates and T-cell engagers, Bright Biologics aims to combat the heterogeneity of tumors, which is a primary factor in relapse when using traditional monospecific therapies. Their pioneering approaches are designed to target multiple cancer cell subpopulations, ultimately improving clinical outcomes for patients.
Generated from the website